Cystatin C, Renal Function, and Cardiovascular Risk

  1. Pierre Delanaye, MD;
  2. Etienne Cavalier, MD; and
  3. Jean-Marie Krzesinski, MD, PhD
  1. From University of Liège, CHU Sart Tilman, B-9000 Liège, Belgium.

    TO THE EDITOR:

    We read with interest the article by Menon and colleagues (1) concerning cystatin C as a cardiovascular risk factor. We believe their paper considerably increases the quality of articles published on this topic, especially because glomerular filtration rate (GFR) was measured with a reference method.

    We have some comments. First, it is important to keep in mind that this study analyzes cystatin C as a cardiovascular risk factor. Because all the patients had chronic kidney disease (CKD) (GFR <55 mL/min per 1.73 m2), this …

    « Previous | Next Article »Table of Contents